Clinical Trials Browser

Phase 1/2 × Congenital Abnormalities × laromustine × Clear all

NCT00840684 2011-05-13

Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia

Phase 1/2 Completed

Other hematologic neoplasm

Congenital Abnormalities, Leukemia